1. Sengoku T, Shiina M, Suzuki K, Hamada K, Sato K, Uchiyama A, Kobayashi S, Oguni A, Itaya H, Kasahara K, Moriwaki H, Watanabe C, Honma T, Okada C, Baba S, Ohta T, Motohashi H, Yamamoto M, and Ogata K. Structural basis of transcription regulation by CNC family transcription factor, Nrf2. Nucleic Acids Res (2022) 50 (21): 12543-12557 doi:10.1093/nar/gkac1102
2. Sies H, Belousov VV, Chandel NS, Davies MJ, Jones DP, Mann GE, Murphy MP, Yamamoto M, and Winterbourn C. Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology. Nature Rev Mol Cell Biol (2022) 23 (7): 499-515 doi: 10.1038/s41580-022-00456-z
3. Hirose W, Horiuchi M, Li D, Motoike IN, Zhang L, Nishi H, Taniyama Y, Kamei T, Suzuki M, Kinoshita K, Katsuoka F, Taguchi K, and Yamamoto M. Selective Elimination of NRF2-Activated Cells by Competition with Neighboring Cells in the Esophageal Epithelium. Cell Mol Gastroenterol Hepatol (2022) 15 (1): 153-178 doi:10.1016/j.jcmgh.2022.09.004
4. Kuga A, Tsuchida K, Panda H, Horiuchi M, Otsuki A, Taguchi K, Katsuoka F, Suzuki M, and Yamamoto M. The β-TrCP-Mediated Pathway Cooperates with the Keap1-Mediated Pathway in Nrf2 Degradation In Vivo. Mol Cell Biol (2022) 42 (7): e0056321 doi:10.1128/mcb.00563-21
5. Panda H, Suzuki M, Naito M, Saito R, Wen H, Baird L, Uruno A, Miyata K, and Yamamoto M. Halofuginone micelle nanoparticles eradicate Nrf2-activated lung adenocarcinoma without systemic toxicity. Free Radic Biol Med (2022) 187: 92-104 doi: 10.1016/j.freeradbiomed.2022.05.017